Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Compumedics.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
Health & Biotech
Health Check: It’s goodbye to ugly grey ‘gob filler’ as SDI’s aesthetic alternative gains traction
Health & Biotech
Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair
News
Market Highlights: Analysts see Nvidia as good pick up, and why investors will be on edge tonight
Health & Biotech
Wake Up! Don’t get caught sleeping on these three dreamy stocks
Health & Biotech
ASX Health Stocks: Amplia sees new success in pancreatic cancer trial
News
Market Highlights: Not much spared on chopping block after another big selloff, Wall Street loses US$3.5 trillion
Health & Biotech
Dr Boreham’s Crucible: Sleep diagnostics stayer is still dreaming big
News
CLOSING BELL: Big Coal fires up the Energy sector, but not enough to stop the rot
Health & Biotech
ASX Health Winners January: ‘Invest in business not science’, as SHG and PAA top winners list
Health & Biotech
The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
News
Hot Money Monday: Beware of ‘mean reversion’ as Compumedics, Fatfish surge on momentum
News
In Case You Missed It: Iron ore, oil fields and medical diagnostics deals
News
Market Highlights: SEC approves these 11 Bitcoin ETFs overnight, and 5 small caps to watch today
Health & Biotech
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
Health & Biotech
